Zheng YL - Search Results

1

BPDE-induced lymphocytic 3p21.3 aberrations may predict head and neck carcinoma risk.

Zhu Y, Spitz MR, Zheng YL, Hong WK, Wu X. Zhu Y, et al. Among authors: zheng yl. Cancer. 2002 Aug 1;95(3):563-8. doi: 10.1002/cncr.10689. Cancer. 2002. PMID: 12209748 Free article.

2

Mutagen-induced chromatid breakage as a marker of cancer risk.

Wu X, Zheng YL, Hsu TC. Wu X, et al. Among authors: zheng yl. Methods Mol Biol. 2005;291:59-67. doi: 10.1385/1-59259-840-4:059. Methods Mol Biol. 2005. PMID: 15502212

3

Cell cycle checkpoints, DNA damage/repair, and lung cancer risk.

Wu X, Roth JA, Zhao H, Luo S, Zheng YL, Chiang S, Spitz MR. Wu X, et al. Among authors: zheng yl. Cancer Res. 2005 Jan 1;65(1):349-57. Cancer Res. 2005. PMID: 15665313

4

Less efficient g2-m checkpoint is associated with an increased risk of lung cancer in African Americans.

Zheng YL, Loffredo CA, Alberg AJ, Yu Z, Jones RT, Perlmutter D, Enewold L, Krasna MJ, Yung R, Shields PG, Harris CC. Zheng YL, et al. Cancer Res. 2005 Oct 15;65(20):9566-73. doi: 10.1158/0008-5472.CAN-05-1003. Cancer Res. 2005. PMID: 16230422 Free PMC article.

5

Telomere attrition in cancer cells and telomere length in tumor stroma cells predict chromosome instability in esophageal squamous cell carcinoma: a genome-wide analysis.

Zheng YL, Hu N, Sun Q, Wang C, Taylor PR. Zheng YL, et al. Cancer Res. 2009 Feb 15;69(4):1604-14. doi: 10.1158/0008-5472.CAN-08-3028. Epub 2009 Feb 3. Cancer Res. 2009. PMID: 19190333 Free PMC article.

6

Mutagen sensitivity as measured by induced chromatid breakage as a marker of cancer risk.

Wu X, Zheng YL, Hsu TC. Wu X, et al. Among authors: zheng yl. Methods Mol Biol. 2014;1105:183-92. doi: 10.1007/978-1-62703-739-6_15. Methods Mol Biol. 2014. PMID: 24623229

7

Chromosome 9 arm-specific telomere length and breast cancer risk.

Zheng YL, Loffredo CA, Shields PG, Selim SM. Zheng YL, et al. Carcinogenesis. 2009 Aug;30(8):1380-6. doi: 10.1093/carcin/bgp151. Epub 2009 Jun 17. Carcinogenesis. 2009. PMID: 19535548 Free PMC article. Clinical Trial.

8

Telomere length in blood cells and breast cancer risk: investigations in two case-control studies.

Zheng YL, Ambrosone C, Byrne C, Davis W, Nesline M, McCann SE. Zheng YL, et al. Breast Cancer Res Treat. 2010 Apr;120(3):769-75. doi: 10.1007/s10549-009-0440-z. Epub 2009 Jun 19. Breast Cancer Res Treat. 2010. PMID: 19543829 Free PMC article.

9

Elevated lung cancer risk is associated with deficiencies in cell cycle checkpoints: genotype and phenotype analyses from a case-control study.

Zheng YL, Kosti O, Loffredo CA, Bowman E, Mechanic L, Perlmutter D, Jones R, Shields PG, Harris CC. Zheng YL, et al. Int J Cancer. 2010 May 1;126(9):2199-210. doi: 10.1002/ijc.24771. Int J Cancer. 2010. PMID: 19626602 Free PMC article.

10

Phytohemagglutinin-induced mitotic index in blood lymphocytes: a potential biomarker for breast cancer risk.

Kosti O, Byrne C, Cocilovo C, Willey SC, Zheng YL. Kosti O, et al. Among authors: zheng yl. Breast Cancer (Auckl). 2010 Dec 15;4:73-83. doi: 10.4137/BCBCR.S6307. Breast Cancer (Auckl). 2010. PMID: 21234289 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

777 results

Search Page

Filters